Status:
COMPLETED
Red Light Intervention for Myopia Prevention
Lead Sponsor:
Shanghai Eye Disease Prevention and Treatment Center
Conditions:
Myopia
Eligibility:
All Genders
6-11 years
Phase:
NA
Brief Summary
To explore the effectiveness of using low-intensity single-wavelength red light to prevent myopia in schoolchildren, and to provide a feasible scheme for reducing the incidence of myopia.
Eligibility Criteria
Inclusion
- Students of grade 1-4 in the participating schools;
- Students' eyes have no myopia, that is the cycloplegic spherical equivalent（SE） \>-0.50D, and at least one eye accords with the pre-myopic state, that is -0.50D \<cycloplegic SE≤0.50D;
- Students whose mother and/or father are in myopia status (SE \< -3.0D for either of eyes);
- Students whose parents sign informed consent and agree to let their kids participate in baseline screen and follow-up examinations and surveys.
Exclusion
- Students whose parents do not sign informed consent;
- Students who have strabismus and/or other binocular vision abnormality;
- Students who have other eye diseases and/or systematic diseases;
- Students who have DC \<=-1.5D;
- Students whose difference of SE between the two eyes \>=1.5D;
- Students who meet the standards with which investigators and study physicians think it is not appropriate to enroll.
Key Trial Info
Start Date :
March 25 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
278 Patients enrolled
Trial Details
Trial ID
NCT04825769
Start Date
March 25 2021
End Date
August 31 2022
Last Update
September 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiangui He
Shanghai, Shanghai Municipality, China, 200040